Strengthening research capacity

Evaluation of Chlorfenapyr applied as an IRS for control of pyrethroid resistant Anopheles gambiae and Culex quinquefasciatus: a household randomized trial in southern Benin

Lead researcher: 

This study assessed whether the efficacy of a moderate dosage (250mg/m2) of chlorfenapyr applied as IRS within rural Beninese villages could rival that of the standard pyrethroid alphacypermethrin (25mg/m2) or the carbamate bendiocarb (400mg/m2) currently deployed for IRS in area with high pyrethroid resistance. The results indicated a steady decay of all 3 treatments over time in terms of personal protection and mortality of An. gambiae. The comparative performance within local huts in southern Benin and through bioassays with 250mg/m2 chlorfenapyr IRS indicated a shorter term gain in control of pyrethroid resistant mosquitoes than bendiocarb 400mg/m2 or alphacypermethrin 25mg/m2. Instead, the bioassay data suggest that higher chlorfenapyr dosage, e.g. 500mg/m2 or above would be ideal dosages to consider during spray campaigns in pyrethroid resistant areas. Comparative trials including 500mg/m2 chlorfenapyr should be undertaken in experimental and at household level in similar areas with resistance.

Learn more about mentoring through our Open Access Mentoring Module.

Access the grant system (for MCDC members only)

Follow us:

Contact us

MCDC | London School of Hygiene & Tropical Medicine
Keppel Street